...Jim Nakashima; Makoto Sumitomo; Akira Miyajima; Seido Jitsukawa; Masaru Murai Procollagen 1 carboxyterminal peptide (PICP) is thought to be an indicator of new bone formation. The present report demonstrates that effective endocrine therapy induced an initial increase followed by a delayed decrease...

...Kenjiro Kohri; Takanori Yamate; Hirononi Tsujihashi; Yuzo Nakao; Yoshikazu Katayama; Yasushi Hara; Yasuyuki Morikawa; Takashi Kurita We describe a 62-year-old male with brain metastasis from prostatic carcinoma, which regressed with medical and surgical endocrine therapies. The patient’s presenting...

...Tohru Shinkawa; Tetsuro Ohfuji; Yukio Osada; Nobuyuki Ishisawa A clinical study of the adverse effects induced by the endocrine therapy with a high dose of estrogen in 45 patients with stage C or D prostatic carcinoma is conducted. Transient decreases of hemoglobin and serum protein values were...

.... Among 46 cases of untreated prostatic cancer examined, 76% were fluorescence-positive. 7 cases out of 9 who had relapsed from endocrine therapy showed negative fluorescence. It was concluded that the fluorescence in the tissue sections of the untreated prostatic cancer were well correlated...

... was assessed using Cox’s proportional hazards model analyses in 126 prostate cancer patients with metastases treated with endocrine therapy. Results: Serum levels of CRP, PSA and ALP significantly increased and hemoglobin significantly decreased with advancing EOD grade. Univariate analysis demonstrated...

...Yuzo Furuya; Osamu Nagakawa; Hideki Fuse Objective: Endocrine therapy is the standard treatment for metastatic prostate cancer although progression to androgen independence is inevitable. To evaluate prognostic factors in metastatic prostate cancer, patients who had been treated with endocrine...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate cancer Endocrine therapy Antiandrogen Bicalutamide LNCaP cells Androgen receptor Original Paper Urol Int...

... rate was 45.8%. Patients without bone metastases at the initial diagnosis could survive longer than those with metastases to bone (p < 0.05). Conclusions: From these observations, endocrine therapy was effective even in patients with distant lymph node metastases. Prostate cancer Endocrine...

... in metastatic prostate cancer, patients who had been treated with endocrine therapy were investigated. Methods: One hundred and thirty-nine patients with untreated metastatic prostate cancer (TxNxM1) who received endocrine therapy between 1986 and 1993 were included in the present study. Blood chemistry...